SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: TobagoJack who wrote (157774)5/12/2020 11:51:27 AM
From: ggersh  Read Replies (1) | Respond to of 217549
 
WS criminals always win.....that needs to stop

Get BitCoin/Gold




To: TobagoJack who wrote (157774)5/12/2020 12:34:25 PM
From: THE ANT  Read Replies (1) | Respond to of 217549
 
SRPT still not expensive Roche bought at $150 and SRPT has 2 billion in cash and 500 million a year in sales and something I think like 38 drugs in the pipe line. Most of all they rule the science. Even the FDA will have to defer to them. I think biotech analyst might be a good job for the Coconut. Lots of freedom and most in the field don't keep up on years of happening or don't know the science


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News